A controversy has erupted
in New Zealand over the funding
of the PHARMAC scheme, which
opposition politicians warn could
see Kiwis “potentially missing out
on life-saving medicines”.
District Health Boards in New
Zealand supported a $5 million
increase to PHARMAC’s budget
for 2015-16, whereas PHARMAC
had requested a NZ$10m increase
from NZ$795m to $806m to “meet
previous ministerial expectations
for new investments of $10m in
each year” said the Dominion Post.
PHARMAC chief executive
Steffan Crausaz said the agency
would continue to invest in new
medications from within its current
budget.
“The budget level is only one part
of the equation,” he said.
“Every year PHARMAC secures
between NZ$40m to $60m of
new price concessions and these
savings can also be used to meet
expectations,” he said.The above article was sent to subscribers in Pharmacy Daily's issue from 19 Aug 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Aug 15
THE stark health inequalities between Australians living in regional and metro areas have been highlighted in a new report from The Royal Flying Doctor Service (RFDS).
AN “AI explosion” is sweeping Australia’s healthcare sector, signalling the arrival of an “extraordinary era of medicine”, according to a new report from CSIRO.
THE Australian and New Zealand College of Advanced Pharmacy (ANZCAP) has celebrated the 1,000th pharmacist to complete its pharmacy recognition program (PD 24 Nov 2023).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.